These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 17493504

  • 1. Anaphylactic reactions during immunotherapy.
    Rezvani M, Bernstein DI.
    Immunol Allergy Clin North Am; 2007 May; 27(2):295-307, viii. PubMed ID: 17493504
    [Abstract] [Full Text] [Related]

  • 2. Subcutaneous Immunotherapy Safety: Incidence per Surveys and Risk Factors.
    Sánchez-Borges M, Bernstein DI, Calabria C.
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):25-39. PubMed ID: 31761119
    [Abstract] [Full Text] [Related]

  • 3. Allergen immunotherapy: an updated review of safety.
    James C, Bernstein DI.
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):55-59. PubMed ID: 27906697
    [Abstract] [Full Text] [Related]

  • 4. Anaphylaxis: still a ghost behind allergen immunotherapy.
    Makatsori M, Calderon MA.
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):316-22. PubMed ID: 24873937
    [Abstract] [Full Text] [Related]

  • 5. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
    Bukantz SC, Bagg AS, Lockey RF.
    Clin Allergy Immunol; 2008 Aug; 21():455-68. PubMed ID: 18828523
    [No Abstract] [Full Text] [Related]

  • 6. Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.
    Caminati M, Dama AR, Djuric I, Montagni M, Schiappoli M, Ridolo E, Senna G, Canonica GW.
    Expert Rev Clin Immunol; 2015 Feb; 11(2):233-45. PubMed ID: 25484197
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
    Ohashi Y, Nakai Y, Tanaka A, Kakinoki Y, Washio Y, Ohno Y, Yamada K, Nasako Y.
    Acta Otolaryngol Suppl; 1998 Feb; 538():113-7. PubMed ID: 9879410
    [Abstract] [Full Text] [Related]

  • 8. Incidence and characteristics of biphasic reactions after allergen immunotherapy.
    Scranton SE, Gonzalez EG, Waibel KH.
    J Allergy Clin Immunol; 2009 Feb; 123(2):493-8. PubMed ID: 19064282
    [Abstract] [Full Text] [Related]

  • 9. [Adverse reactions to skin tests and immunotherapy in the practice of Mexican allergologists].
    Larenas Linnemann D, Rodríguez Pérez N, Becerril M.
    Rev Alerg Mex; 2008 Feb; 55(2):62-70. PubMed ID: 19058483
    [Abstract] [Full Text] [Related]

  • 10. Food anaphylaxis.
    Branco Ferreira M, Palma-Carlos A.
    Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):387-91. PubMed ID: 16528902
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of near-fatal reactions to allergen immunotherapy injections.
    Amin HS, Liss GM, Bernstein DI.
    J Allergy Clin Immunol; 2006 Jan; 117(1):169-75. PubMed ID: 16387602
    [Abstract] [Full Text] [Related]

  • 12. Systemic reactions to subcutaneous allergen immunotherapy.
    Bernstein DI, Epstein T.
    Immunol Allergy Clin North Am; 2011 May; 31(2):241-9, viii-ix. PubMed ID: 21530817
    [Abstract] [Full Text] [Related]

  • 13. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System.
    Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G.
    J Allergy Clin Immunol; 2010 Mar; 125(3):569-74, 574.e1-574.e7. PubMed ID: 20144472
    [Abstract] [Full Text] [Related]

  • 14. Systemic Allergic Reactions and Anaphylaxis Associated with Allergen Immunotherapy.
    Dhamija Y, Epstein TEG, Bernstein DI.
    Immunol Allergy Clin North Am; 2022 Feb; 42(1):105-119. PubMed ID: 34823741
    [Abstract] [Full Text] [Related]

  • 15. Immunotherapy safety: what have we learned from surveillance surveys?
    Kannan JA, Epstein TG.
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):381-8. PubMed ID: 23636820
    [Abstract] [Full Text] [Related]

  • 16. The safety of allergen immunotherapy: a literature review.
    Cook PR, Farias C.
    Ear Nose Throat J; 1998 May; 77(5):378-9, 383-8. PubMed ID: 9615518
    [Abstract] [Full Text] [Related]

  • 17. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.
    Bernstein DI, Wanner M, Borish L, Liss GM, Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology.
    J Allergy Clin Immunol; 2004 Jun; 113(6):1129-36. PubMed ID: 15208595
    [Abstract] [Full Text] [Related]

  • 18. Systemic reactions to subcutaneous immunotherapy: Effects of dosing and aeroallergen content.
    Mustafa SS, Bingemann T, Blue H, Conn K, Hanley T, Ramsey A.
    Ann Allergy Asthma Immunol; 2019 Sep; 123(3):284-287. PubMed ID: 31276805
    [Abstract] [Full Text] [Related]

  • 19. Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy.
    Bernstein DI, Epstein TEG.
    Allergy Asthma Proc; 2020 Mar 01; 41(2):108-111. PubMed ID: 32122446
    [Abstract] [Full Text] [Related]

  • 20. Safety of subcutaneous allergen immunotherapy.
    Bernstein DI, Epstein TG.
    Allergy Asthma Proc; 2022 Jul 01; 43(4):267-271. PubMed ID: 35818150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.